Oxidative stress;Le stress oxydant

Revue Medicale de Liege

Volumn 62, Issue 10, 2007, Pages 628-638

  Haleng, J ^a   Pincemail, J ^a   Defraigne, J O ^a   Charlier, C ^a   Chapelle, J P ^a  

^a CHU SART TILMAN   (Belgium)

Author keywords

Antioxidants; Biological markers; Oxidative stress

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BILIRUBIN; CAROTENOID; DNA; GLUCOSE; GLUTATHIONE; LIPID; LIPOPROTEIN; POLYPHENOL; PROTEIN; PROTEIN KINASE C; REACTIVE OXYGEN METABOLITE; SELENIUM; SUPEROXIDE DISMUTASE; THIOREDOXIN; UBIDECARENONE; URIC ACID; ZINC; ADVANCED GLYCATION END PRODUCT; AMINO ACID; BIOLOGICAL MARKER; DRUG DERIVATIVE; FREE RADICAL; GLUTATHIONE PEROXIDASE; MEMBRANE LIPID; MULTIENZYME COMPLEX; SUPEROXIDE; TRACE ELEMENT; UBIQUINONE; VITAMIN;

AGING; ALCOHOLISM; ARTICLE; CARDIOVASCULAR DISEASE; DIABETES MELLITUS; DNA DAMAGE; ENZYME ACTIVATION; EXERCISE; GLUCOSE OXIDATION; LIFESTYLE; LIPID MEMBRANE; NEOPLASM; OBESITY; OXIDATIVE STRESS; PATHOLOGY; SMOKING; COENZYME; HUMAN; METABOLISM; PHYSIOLOGY;

AMINO ACIDS; ANTIOXIDANTS; ASCORBIC ACID; BIOLOGICAL MARKERS; CAROTENOIDS; COENZYMES; DIABETES MELLITUS; DNA DAMAGE; ELECTRON TRANSPORT CHAIN COMPLEX PROTEINS; FREE RADICALS; GLUTATHIONE PEROXIDASE; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; LIPOPROTEINS; MEMBRANE LIPIDS; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; SUPEROXIDE DISMUTASE; SUPEROXIDES; THIOREDOXINS; TRACE ELEMENTS; UBIQUINONE; VITAMIN E; VITAMINS;

EID: 38849191820     PISSN: 00353663     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Delattre J, Beaudeux J-L, Bonnefont-Rousselot D. - Radicaux libres et stress oxydant, aspects biologiques et pathologiques. Première édition. Ed. Tee et Doc, Lavoisier, Paris, 2005, 547 pages.
2. Hare J. - Nitroso-redox balance in the cardiovascular system. N Engl J Med, 2004, 351, 2112-2114.
3. Atkin MA, Gasper A, Ullegaddi R, et al. - Oxidative susceptibility of unfractioned serum or plasma : response to antioxidants in vitro and to antioxidants supplementation. Clin Chem, 2005, 51, 2138-2144.
4. Nakajima K, Nakano T, Tanaka A. - The oxidative modification hypothesis of atherosclerosis : The comparison of atherogenic effects on oxidized LDL and remnant lipoproteins in plasma. Clin Chim Acta, 2006, 367, 36-47.
5. Saad A, Virella G, Chassereau Ch, et al. - OxLDL immune complexes activate complement and induce cytokine production by MonoMac 6 cells and human macrophages. J Lipid Res, 2006, 47, 1975-1983.
6. Hozawa A, Jacobs D, Steffes M, et al. - Relationships of circulating carotenoid concentrations with several markers of inflammation, oxidative stress, and endothelial dysfunction : the Coronary Artery Risk Developpement in Young Adults (CARDIA)/ Young Adult Longitudinal Trends in Antioxidants (YALTA) Study. Clin Chem, 2007, 53, 1-9.
7. Langsjoen PH, Langsjoen AM. - The clinical use of HMG CoA - reductase inhibitors and the associated depletion of coenzyme Q10-A review of animal and human publications. Biofactors, 2003, 18, 101-111.
8. Defraigne J-O. - Un mécanisme physiopathologique central à l'origine des complications du diabète ? Rev Med Liege, 2005, 60, 472-478.
9. Vincent HK, Taylor AG. - Biomarkers and potential mechanisms of obesity-induced oxidant stress in humans. Int J Obesity, 2006, 30, 400-418.
10. Selvaraj N, Bobby Z, Sathiyapriya V. - Effect of lipid peroxides and antioxydants on glycation of hemoglobin: an in vitro study on human erythrocytes. Clin Chim Acta, 2006, 366, 190-195.
11. Hudson BI, Wendt T, Bucciarelli LG, et al. - Diabetic vascular disease : it's all the RAGE. Antioxid Redox Signal, 2005, 7, 1588-1600.
12. Wautier J-L. - Récepteurs des produits de glycation avancée et diabète sucré. Sang Thrombose Vaisseaux, 1997, 9, 637-641.
13. Rodríguez-García J, Requena J, Rodríguez-Segade S. - Increased concentrations of serum pentosidine in rheumatoid arthritis. Clin.Chem, 1998, 44, 250-255.
14. Pullerits R, Bokarewa M, Dahlberg L, Tarkowski A. - Decreased levels of soluble receptor for advanced glycation end products in patients with rheumatoid arthritis indicating deficient inflammatory control. Arthritis Res Therapy, 2005, 7, 817-824.
15. Devaraj S, Hirany Sh, Burk R, et al. - Divergence between LDL oxidative susceptibility and urinary F2-isoprostanes as measures of oxidative stress in type 2 diabetes. Clin Chem, 2001, 47, 1974-1979.
16. Pincemail J, Defraigne JO, Limet R. - Oxidative stress in clinical situations - fact or fiction ? Eur J Anaesthesiol, 1996, 13, 219-234.
17. Dalle-Donne I, Rossi R, Colombo R, et al. - Biomarkers of oxidative damage in human disease. Clin Chem, 2006, 52, 601-623.
18. Gey KF. - Vitamins E plus C and interacting conutrients required for optimal health. A critical and constructive review of epidemiology and supplementation data regarding cardiovascular disease and cancer. Biofactors, 1998, 7, 113-174.
19. Pincemail J, Vanbelle S, Gaspard U, et al. - Relationship between oxidative stress and the taking of oral contraceptives in women aged 40-48 years. Human Reprod, 2007, in press.
20. Tsimikas S. - Measures of oxidative stress. Clin Lab Med, 2006, 26, 571-590.
21. Gross M, Steffes M, Jacobs D, et al. - Plasma F2-isoprostanes and coronary artery calcification : The CARDIA Study. Clin Chem, 2005, 51, 125-131.
22. Young IS. - Oxidative stress and vascular disease : insights from isoprostane measurement. Clin Chem, 2005, 51, 14-15.
23. Tsimikas S, Brilakis ES, Miller ER, et al. - Oxidized phospholipids, Lp(a) lipoprotein, and coronary artery disease. N Engl J Med, 2005, 353, 46-57.
24. Holvoet P, Kritchevsky SB, Tracy RP, et al. - The metabolic syndrome, circulating oxidized LDL, and risk of myocardial infarction in well-functioning elderly people in the health, aging, and body composition cohort. Diabetes, 2004, 53, 1068-1073.
25. Holvoet P, Vanhaecke J, Janssens S, et al. - Oxidized LDL and malondialdehyde-modified LDL in patients with acute coronary syndromes and stable coronary artery disease. Circulation, 1998, 98, 1487-1494.
26. Nishi K, Itabe H, Uno M, et al. - Oxidized LDL in carotid plaque and plasma associates with plaque instability. Arterioscl Thromb Vasc Surg, 2002, 22, 1649-1659.
27. Chen Ch, Qu L, Li B, et al. - Increased oxidative DNA damage, as assessed by urinary 8-hydroxy-2'-deoxyguanosine concentrations, and serum redox status in persons exposed to mercury. Clin Chem, 2005, 51, 759-767.
28. Lemarechal H, Allanore Y, Chenevier-Gobeaux, et al. - Serum protein oxidation in patients with rheumatoid arthritis and effects of infliximab therapy. Clin Chim Acta, 2006, 372, 147-153.
29. Baldus S, Heeschen C, Meinertz T, et al. - Myeloperoxydase serum levels predict risk in patients with acute coronary syndromes. Circulation, 2003, 108, 1440-1445.
30. David J-L. - L'hyperhomocystéimémie, facteur de risque thrombo-embolique veineux. Louvain Medical, 2000, 119, 191-196.
31. Guohua Cao, Ronald L. - Prior Comparison of different analytical methods for assessing total antioxidant capacity of human serum. Clin Chem, 1998, 44, 1309-1315.
32. Pincemail J, Degrune F, Voussure S, et al. - Effet d'une alimentation riche en fruits et légumes sur les taux plasmatiques en antioxydants et des marqueurs des dommages oxydatifs. Nutrition Clin Metab, 2007, 21, 66-75.
33. Rabovsky A, Cuomo J, Eich N. - Measurement of plasma antioxidant reserve after supplementation with various antioxidants in healthy subjects. Clin Chim Acta, 2006, 371, 55-60.